Back to all webinars
Can we change unresectable NSCLC into resectable NSCLC?
Luis Paz-Ares and Carlos Gil Ferreira review clinical approaches to treating unresectable and resectable NSCLC and highlight emerging data on the efficacy of chemo-IO induction therapy in locally advanced disease.
Speakers
Clinical data for the treatment of unresectable/ resectable disease
No entries
Defining resectable/ unresectable disease
No entries
Induction therapy for locally advanced disease
No entries
Surgery in advanced disease
No entries
Extent of surgery, triple therapy, and oncogene addiction
No entries
Summary
No entries